However, as sarcopenia progresses, it is likely that poor muscle function, rather than reduced muscle mass, may drive the association between sarcopenia and late‐life cognitive impairment [28], which could explain the negative association between TMT and AD, as well as the later tau PET Braak stage (III‐VI) SUVR values observed in our study. This evidence concerns the gene MAPT and Cognitive impairment.